Stay updated with breaking news from Bloom Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows.
NEW YORK, Oct. 9, 2023 /PRNewswire/ -- In cases where standard therapies fail, an investigational medication called XEN1101 reduces seizure freque...
Research on the gut/brain axis is fueling the development of new therapies for neurological conditions including Dravet syndrome, ALS, and autism-related irritability.
/PRNewswire/ -- Bloom Science, Inc., a clinical-stage, central nervous system (CNS) company focused on discovering and developing breakthrough therapeutics...
Scientists have decoded the genetic makeup of Akkermansia, a gut bacterium that could help manage cholesterol levels.